GERA - Medicina Reprodutiva

What GERA - Medicina Reprodutiva does

GERA - Medicina Reprodutiva is a private, physician-founded reproductive medicine clinic headquartered in São Paulo, Brazil, established in 1993 by Prof. Dr. Joji Ueno, one of the recognized pioneers of in vitro fertilization in the country. The clinic delivers a comprehensive suite of high- and low-complexity assisted reproduction services, including IVF (Fertilização in Vitro), ICSI (Intracytoplasmic Sperm Injection), intrauterine insemination, egg and sperm freezing, preimplantation genetic diagnosis (PGD), and adjacent surgical procedures such as vasectomy reversal, tubal ligation reversal, and varicocele repair. Patient cohorts span heterosexual couples with infertility, LGBTQIA+ families, cancer patients seeking pre-treatment fertility preservation (oncofertility), women electing to defer pregnancy, and male-factor infertility cases. Operations are anchored by the AUREA Centro de Fertilidade laboratory and the affiliated Instituto GERA education and research institute, alongside the social program Projeto Girassol, which offers subsidized fertility treatments to young couples with limited financial resources.

The clinic's medical staff comprises gynecologists exclusively holding master's or doctorate degrees from USP (Universidade de São Paulo) and UNIFESP (Universidade Federal de São Paulo), several of whom hold adjunct academic appointments at those universities and at Hospital Nove de Julho. The technology stack referenced includes the VIOLET™ AI system for egg-freezing procedures, embryoscope time-lapse embryo monitoring, laser-assisted embryo handling for PGD, and a dedicated embryology laboratory. Reported clinical outcomes include a 50% pregnancy rate for women under 35 using own eggs, 40% for ages 36–37, and an 85.2% success rate for egg freezing at age 30 with donor sperm — positioned against a Brazilian IVF market running approximately 25,000 cycles per year under Resolução nº 2.116/2015, which formally recognizes assisted reproduction as a practice area.

GERA operates a professional-services revenue model with quote-based, pay-as-you-go pricing per treatment cycle (egg freezing reported at approximately 10,000–20,000 BRL plus 100–150 BRL monthly storage). Go-to-market is direct-to-patient via WhatsApp booking and in-person consultation at the São Paulo HQ in Jardim Paulista, supplemented by additional clinic locations in Campo Grande and Passo Fundo, and supported by content marketing through an educational blog plus Instagram and YouTube channels. Disclosed revenue, full headcount, and patient throughput are not publicly available; the firmographic lists 12 employees while the website references approximately eight named physicians, indicating a small, specialist, owner-operated private practice rather than a scaled multi-site chain.

Name

GERA - Medicina Reprodutiva

Legal name

Clínica GERA

Website

https://clinicagera.com.br

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

GERA - Medicina Reprodutiva is a São Paulo private reproductive medicine clinic founded in 1993 that delivers IVF, ICSI, egg freezing, PGD, and oncofertility services to individuals, couples, and LGBTQIA+ families, staffed exclusively by USP/UNIFESP professor gynecologists and the AUREA laboratory.

Ownership category

akta.pro rank

Product category

Reproductive Medicine Services

NAICS

Family Planning Centers (621410)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Reproductive medicine services
• In vitro fertilization
• Fertility preservation
• Assisted reproduction treatments
• Cryopreservation services

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Consultation and Treatment Services: Revenue generated from fertility consultations, diagnostic assessments, and reproductive treatments including IVF, ICSI, egg freezing, sperm preservation, and related procedures. Services include ovarian induction, egg retrieval, embryo transfer, and fertility preservation.
2. Project Girassol - Subsidized Treatment Program: Reduced-cost fertility treatments for young couples with limited financial resources, offering accessible consultation and treatment options with installment payment plans.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

GERA is a reproductive medicine clinic in São Paulo, Brazil providing high-complexity assisted reproduction treatments including in vitro fertilization (IVF), ICSI, egg freezing, sperm preservation, and preimplantation genetic diagnosis. The clinic also offers LGBTQIA+ family planning, oncofertility, male infertility surgery (varicocele, vasectomy reversal), and minimally invasive gynecologic surgery. Services are delivered by physician-professors trained at USP and UNIFESP, with the modern AUREA fertility laboratory supporting all procedures.

Product overview

GERA is a reproductive medicine clinic offering a comprehensive portfolio of assisted reproduction treatments. The core offerings include Fertilização in Vitro (IVF), Inseminação Intrauterina (IIU), ICSI, egg and embryo freezing (cryopreservation), and fertility preservation services. The clinic provides specialized services for male factor infertility including varicocele treatment and vasectomy reversal, as well as LGBTQIA+ family planning. Advanced technologies include the VIOLET™ AI system for egg freezing, embryoscope monitoring for embryo development, and preimplantation genetic diagnosis (PGD). The AUREA Centro de Fertilidade serves as the modern laboratory facility. GERA also operates Projeto Girassol as a social program for affordable fertility treatments. All services are delivered by board-certified physician professors with master's or doctoral degrees from USP and UNIFESP.

Differentiator

Problem solved

Functional benefit

Brands

• Instituto GERA: Education and Research Institute in Reproductive Medicine founded by the GERA group, offering training and research programs.
• AUREA - Centro de Fertilidade
• Projeto Girassol

Quantifiable outcome

• 50% pregnancy rate for women up to 35 years with own eggs
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• USP - Universidade de São PaulocoreStrategic or Co-development PartnerActive research partnerships with USP. Medical staff trained at USP include founders and physicians who conduct academic research and postgraduate supervision at the university.
• UNIFESP - Universidade Federal de São PaulocoreStrategic or Co-development PartnerResearch partnerships and medical staff with Master's/Doctorate degrees from UNIFESP. Continued academic collaboration in reproductive medicine education and research.
• Hospital Nove de JulhocoreStrategic or Co-development PartnerProf. Dra. Marise Samama serves as head of Oncofertility and Human Reproduction sector at Hospital Nove de Julho.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Others

• Igenomix: Reproductive genetics laboratory offering PGT-A, PGT-M and carrier screening. Directly comparable to GERA's PGD service capability and operates as a potential partner or substitute in genetics-driven embryo selection.
• CooperSurgical: US supplier of IVF/ART consumables, lab devices, and donor egg programs. Comparable in serving the fertility clinic market at the equipment and supply layer rather than direct clinical services.
• Vitrolife: Swedish supplier of IVF media, consumables and the EmbryoScope time-lapse incubator used by GERA. Adjacent rather than competitive; supplies the technology ecosystem GERA operates within.

Broad incumbents

• IVI-RMA Global: Global fertility network (KKR-backed) operating across Europe, the Americas and the Middle East. Offers the same IVF/ICSI/PGT/preservation services as GERA with proprietary lab technology and significantly larger scale, including expansion into Brazilian-adjacent markets.
• Shady Grove Fertility: US fertility giant (now part of Unified Women's Healthcare). Comparable in offering IVF, ICSI, PGT and LGBTQIA+ family building with a national US footprint and shared-risk financial programs.
• Boston IVF: Large US fertility network offering comprehensive IVF, PGD, fertility preservation and LGBTQIA+ family building. Highly comparable service portfolio to GERA at significantly larger scale and with affiliated research programs.
• Genea: Australian fertility group with strong technology DNA (via sister company Genea Biomedx) offering fertility treatments, time-lapse incubation and academic affiliations. Comparable to GERA in physician-led brand and lab technology investment.
• Inception Fertility: US parent of Prelude, Vivere and other fertility brands operating a comprehensive reproductive medicine portfolio with technology-forward positioning. Comparable to GERA in service breadth but with multi-brand scale.
• CCRM Fertility: US-headquartered fertility network with proprietary lab protocols and AI-driven embryo selection. Competes with GERA on medically complex cases and physician-led brand positioning, with a broader geographic footprint.

Direct peers

• Huntington Medicina Reprodutiva: Brazil's largest fertility clinic chain offering IVF, ICSI, PGD and fertility preservation across multiple cities. Directly competes with GERA in São Paulo with a comparable high-complexity service portfolio but at much larger scale and multi-site reach.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/clinicagera
• YouTubeyoutube.com/@clinicagera
• LinkedInlinkedin.com/company/gera-medicina-reprodutiva

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GERA - Medicina Reprodutiva